ARTELO BIOSCIENCES, INC. (ARTL) [Rocket]

In millions, except per share items	Jun-30-23	Mar-31-23	Dec-31-22	Sep-30-22	Jun-30-22	Mar-31-22	Dec-31-21	Nov-30-21
	10-Q	10-Q	10-K	10-Q	10-Q	10-Q	10-K	10-Q
Revenues	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Cost of goods sold	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Gross profit	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Gross margin
Selling, general and administrative [+]	1.0	1.1	1.8	1.3	1.4	1.5	2.1	1.3
General and administrative [+]	1.0	1.1	1.8	1.3	1.4	1.5	2.1	1.3
General and administrative expenses	1.0	1.1	1.8	1.3	1.4	1.5	2.1	1.3
Other selling, general and administrative
Research and development	0.8	1.2	1.7	1.1	1.1	0.5	1.9	1.3
EBITDA [+]
Depreciation and amortization
EBIT [+]	-1.8	-2.3	-3.5	-2.4	-2.5	-1.9	-4.0	-2.6
EBIT growth	-27.8%	17.8%	-14.0%	6.6%	9.6%	14.7%		77.7%
EBIT margin
Interest expense, net [+]				0.0	0.0	0.0		0.0
Interest expense				0.0
Interest income					0.0	0.0		0.0
Other income (expense), net [+]	0.2	0.1	0.1	0.1	0.0	0.0	0.0	0.0
Unrealized gain (loss) on marketable securities				0.1
Pre-tax income	-1.6	-2.2	-3.3	-2.3	-2.4	-2.0	-4.0	-2.5
Income taxes	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Tax rate	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%
Net income	-1.6	-2.2	-3.3	-2.3	-2.4	-2.0	-4.0	-2.5
Net margin

Basic EPS [+]	($0.56)	($0.76)	($1.18)	($0.82)	($0.87)	($0.70)	($1.81)	($0.08)
Growth	-35.3%	8.9%	-34.9%	-40.4%	798.1%	709.4%		-40.4%
Diluted EPS [+]	($0.56)	($0.76)	($1.18)	($0.82)	($0.87)	($0.70)	($1.81)	($0.08)
Growth	-35.3%	8.9%	-34.9%	-40.4%	798.1%	709.4%		-40.4%

Shares outstanding (basic) [+]	2.9	2.9	2.8	2.8	2.8	2.8	2.2	30.4
Growth	0.9%	1.3%	27.0%	74.3%	-87.9%	-85.7%		197.9%
Shares outstanding (diluted) [+]	2.9	2.9	2.8	2.8	2.8	2.8	2.2	30.4
Growth	0.9%	1.3%	27.0%	74.3%	-87.9%	-85.7%		197.9%

EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.